![Thomas Heineman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Heineman
Chief Tech/Sci/R&D Officer at
ONCOLYTICS BIOTECH INC.
Net worth: 140 952 $ as of 2026-08-30
Profile
Thomas C Heineman is Chief Medical Officer at Oncolytics Biotech, Inc. since 2021.
Former positions include Senior Vice President and Head of Clinical Development at Denovo Biopharma LLC in 2020, Vice President and Head of Clinical Development at Halozyme Therapeutics, Inc. from 2018 to 2020, Vice President and Head of Clinical Development at Genocea Biosciences, Inc. from 2016 to 2020, Senior Director of Clinical Research and Development at GSK Plc from 2006 to 2016, and Associate Professor at Saint Louis University School of Medicine.
Education includes graduate and doctorate degrees from The University of Chicago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-31 | 168,201 ( 0.13% ) | 140 952 $ | 2026-08-30 |
Thomas Heineman active positions
| Companies | Position | Start |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Chief Tech/Sci/R&D Officer | 2020-07-31 |
Former positions of Thomas Heineman
| Companies | Position | End |
|---|---|---|
Denovo Biopharma LLC
 Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Manufactures personalize and clinical drugs | Chief Tech/Sci/R&D Officer | 2020-06-30 |
| GENOCEA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 2016-07-31 |
Saint Louis University School of Medicine
 Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Thomas Heineman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Louis University School of Medicine
Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Manufactures personalize and clinical drugs | Health Technology |
- Stock Market
- Insiders
- Thomas Heineman
